Novel psychoactive substances: What educators need to know

Novel psychoactive substances (NPS) are synthetic, psychoactive drugs that are generally not under international regulatory control. NPS are frequently sold as alternatives to classic “street drugs” such as ecstasy or LSD. However, little is known about their pharmacology and toxicity and they there...

Descripción completa

Detalles Bibliográficos
Autores principales: Patterson, ZR, Young, MM, Vaccarino, FJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704356/
https://www.ncbi.nlm.nih.gov/pubmed/27756105
http://dx.doi.org/10.1002/cpt.538
_version_ 1783445490307694592
author Patterson, ZR
Young, MM
Vaccarino, FJ
author_facet Patterson, ZR
Young, MM
Vaccarino, FJ
author_sort Patterson, ZR
collection PubMed
description Novel psychoactive substances (NPS) are synthetic, psychoactive drugs that are generally not under international regulatory control. NPS are frequently sold as alternatives to classic “street drugs” such as ecstasy or LSD. However, little is known about their pharmacology and toxicity and they therefore pose unknown health risks. Further, risk for harms are elevated because users often do not know what they are taking, and therefore cannot predict dose, potency, or other potential properties.
format Online
Article
Text
id pubmed-6704356
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67043562019-08-26 Novel psychoactive substances: What educators need to know Patterson, ZR Young, MM Vaccarino, FJ Clin Pharmacol Ther Perspectives Novel psychoactive substances (NPS) are synthetic, psychoactive drugs that are generally not under international regulatory control. NPS are frequently sold as alternatives to classic “street drugs” such as ecstasy or LSD. However, little is known about their pharmacology and toxicity and they therefore pose unknown health risks. Further, risk for harms are elevated because users often do not know what they are taking, and therefore cannot predict dose, potency, or other potential properties. John Wiley and Sons Inc. 2016-11-29 2017-02 /pmc/articles/PMC6704356/ /pubmed/27756105 http://dx.doi.org/10.1002/cpt.538 Text en © 2016 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Perspectives
Patterson, ZR
Young, MM
Vaccarino, FJ
Novel psychoactive substances: What educators need to know
title Novel psychoactive substances: What educators need to know
title_full Novel psychoactive substances: What educators need to know
title_fullStr Novel psychoactive substances: What educators need to know
title_full_unstemmed Novel psychoactive substances: What educators need to know
title_short Novel psychoactive substances: What educators need to know
title_sort novel psychoactive substances: what educators need to know
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704356/
https://www.ncbi.nlm.nih.gov/pubmed/27756105
http://dx.doi.org/10.1002/cpt.538
work_keys_str_mv AT pattersonzr novelpsychoactivesubstanceswhateducatorsneedtoknow
AT youngmm novelpsychoactivesubstanceswhateducatorsneedtoknow
AT vaccarinofj novelpsychoactivesubstanceswhateducatorsneedtoknow

Ejemplares similares